Weighted Average Number of Shares Outstanding, Diluted of Roivant Sciences Ltd. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Roivant Sciences Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2021 to Q3 2025.
  • Roivant Sciences Ltd. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 681M shares, a 7.41% decline year-over-year.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 725M shares, a 12.7% decline from 2023.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 831M shares, a 16.6% increase from 2022.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 713M shares, a 6.43% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Roivant Sciences Ltd. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 681M -54.5M -7.41% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 680M -101M -13% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 725M -106M -12.7% 01 Jan 2025 31 Mar 2025 10-K 29 May 2025
Q4 2024 723M -122M -14.4% 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2025
Q3 2024 735M -34.8M -4.51% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 782M +22.4M +2.94% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 831M +118M +16.6% 01 Jan 2024 31 Mar 2024 10-K 29 May 2025
Q4 2023 844M +131M +18.4% 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025
Q3 2023 770M +70.3M +10.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 759M +63.4M +9.11% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 713M +43M +6.43% 01 Jan 2023 31 Mar 2023 10-K 29 May 2025
Q4 2022 713M +26.7M +3.89% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024
Q3 2022 700M +49.7M +7.64% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 696M +46M +7.08% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 670M 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2023
Q4 2021 687M 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023
Q3 2021 650M 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 650M 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022

Roivant Sciences Ltd. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 725M -106M -12.7% 01 Apr 2024 31 Mar 2025 10-K 29 May 2025
2023 831M +118M +16.6% 01 Apr 2023 31 Mar 2024 10-K 29 May 2025
2022 713M +43M +6.43% 01 Apr 2022 31 Mar 2023 10-K 29 May 2025
2021 670M 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.